Clay Siegall’s Seattle Genetics: A Company Focused On Antibody Research

Seattle Genetics is a company that has redefined what it means to be a prominent member of the pharmaceutical industry. The company was founded by Clay Siegall and today stands as one of the top research and pharma companies in the state. Seattle Genetics has gone down the unconventional route for its research and focuses on human antibodies and using that as a way to fight a number of diseases and disorders. The company has made an incredible amount of progress since its inception and has come out with life-changing drugs that have aided people diagnosed with these disorders. The company first started its research in the field in 1998 and since then has managed to create a mark in the industry. Today, the company stands as one of the biggest biotech names in the state of Washington. Seattle Genetics currently has over nine hundred employees, with the number steadily growing each year. The company is valued at $10 billion as of July 2017.

One of the main disorders that Seattle Genetics focuses on is cancer. The company has been conducting its research to try and find a way to combat this disease that millions of people all over the world face. Through their research on antibodies, the company aims to take a new approach to cancer treatments, which is something that not a lot of research and pharmaceutical companies are currently doing. Seattle Genetics has come out with various flagship drugs that only they are allowed to produce currently. Numerous doctors all over the country now depend on Seattle Genetics to supply them with the right medicines to help treat the patients who have been diagnosed with cancer.

Clay Siegall has been the backbone and driving force of the company since its inception and is the reason that Seattle Genetics has such a big name in the industry today. Being heavily invested in the field of cancer research, Clay Siegall wanted to build a company that would take a new approach in cancer treatments. Starting up a company of this kind was not easy, and Clay Siegall had to work hard to convince potential investors to invest into the company. He also conducted numerous fundraisers and raised over a million from that alone which went towards the development of Seattle Genetics. Clay Siegall is also an incredible business mind and has been able to guide the company to a position of success in the industry.